Alzheimer’s Research & Therapy is now accepting research papers for consideration in a special series for 2012 on the new FTD mutation on chromosome 9, guest edited by Professor Bruce Miller (University of California, San Francisco).
This series will discuss new advances in frontotemporal dementia (FTD) with amyotrophic lateral sclerosis (ALS) related to mutations in C9orf72. We welcome manuscripts that discuss the clinical and basic science features of this important new mutation.
The publication of these articles will be coordinated with a series of reviews and opinions written by leaders in the field including Bradley Boeve, Neill Graff-Radford, Bryan Traynor, Sharon Sha, Adam Boxer and Jill Goldman, covering a range of topics from genetics to imaging to treatment.
Authors that submit research to this special series will be entitled to a 50% article-processing charge discount. Please quote ‘alzrtFTD50’ on submission to use this offer.
Please submit articles for the special series by 31st May 2012. Please submit your manuscript online and indicate in your covering letter that you would like the article to be considered for the FTD mutation series.
If you would like to enquire about the suitability of a study for consideration, please email firstname.lastname@example.org.
Alzheimer’s Research & Therapy is the major forum for translational research into Alzheimer’s disease and associated conditions. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies.